Master of Biomedical Engineering

2017 - 2020

Amirkabir University of Technology

Iran’s leading biomedical engineering university, ranked 456 worldwide

Since 2017, motivated by personal experience with my mother’s diabetes and the challenges faced by patients, particularly the discomfort and pain of frequent blood glucose measurements, I initiated research on a non-invasive glucose monitoring device.

Simultaneously with my studies, I worked for three years as a biomedical engineer at one of the largest knowledge-based medical device manufacturers in Iran and the Middle East, gaining valuable experience in the design and fabrication of electronic and mechanical boards, as well as in medical device requirements and compliance with FDA and ISO standards.

• Cell culture
• ISO 13485 / FDA 510(k) / IEC 60601
• Electronic board design
• AI & programming
• Data analysis & optimization using AI

Co-Founder – Glycosa

2022 - 2025

Virginia, USA

• Initiated team formation in 2020 and began testing Version 1 of the device at Resalat Laboratory, Iran’s leading diabetes lab.
• Over two years, tested six device versions and, leveraging adaptive AI, achieved +80% accuracy, a first-in-the-world accomplishment.
• Our work has also attracted interest from Roche (Germany) and Novo Nordisk, reflecting the global relevance and potential of our research.
• Since 2022, collaborated with prominent professors from New York University, Howard University, and the University of California.
• Established Glycosa Inc. in the USA to pursue FDA approval and further clinical validation.
• In 2025, we presented our findings at the American Diabetes Association (ADA) Annual Conference, the world’s largest diabetes conference, receiving highly positive feedback from the scientific community.

My Next Frontier

2025 - Present & Beyond

Research & Innovation

As a biomedical engineer and researcher, my work to date—entirely research-focused without any commercial engagements—has aimed to advance the understanding and care of patients with diabetes and cancer. Building on extensive experience in adaptive AI, AI-assisted oncology, and non-invasive biomedical technologies, I aspire to pursue a PhD or research position at a leading institute or clinical center. My goal is to push the frontiers of science, develop innovative solutions, and directly improve patient outcomes, helping individuals return to normal life alongside their loved ones.